Navigation Links
Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results
Date:8/14/2013

WINSTON-SALEM, N.C., Aug. 14, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the second quarter ended June 30, 2013.

"We made strong progress advancing our Neo-Kidney Augment into the clinic this quarter and will continue to focus on this program as well as completing enrollment in our Neo-Urinary Conduit trial. During the quarter, we received a $15.0 million strategic investment from Celgene and completed a $18.6 million financing with other experienced investors to fund our efforts to accomplish these goals," commented John L. Miclot, President and Chief Executive Officer of Tengion. "Following the April approval by the Swedish Medical Products Agency for the Neo-Kidney Augment Phase 1 trial, we began activities to enroll patients with chronic kidney disease. We also continue to actively recruit patients in the Neo-Urinary Conduit Phase 1 trial to further advance that program toward completed enrollment."

Neo-Urinary Conduit Clinical Program Update
Tengion's most advanced product candidate is the Neo-Urinary Conduit, which is designed to replace the standard of care for bladder cancer patients undergoing cystectomy (removal of bladder). The Neo-Urinary Conduit is intended to eliminate the need for bowel resection and the occurrence of typical post-operative co-morbidities associated with current standard of care including urine absorption-related metabolic disorders. It also offers patients potential improvements over the standard of care, including a shorter and less complex surgical procedure, improved recovery times and faster hospital discharges.

Tengion has implanted seven patients with the Neo-Urinary Conduit and is actively seeking to enroll three additional patients by the end of 2013. The trial is designed to translate the surgical procedure successfully used in preclinical animal models into clinical trials with hu
'/>"/>

SOURCE Tengion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Tengion Reports Second Quarter 2012 Financial Results
2. Tengion to Present at the BIO CEO & Investor Conference
3. Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
4. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
7. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
8. Elevate Provides Remote Access to Personal Health Records Using MyMedicalRecords.com
9. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
10. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
11. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
(Date:4/23/2014)... April 23, 2014Men whose testosterone falls below normal levels ... be overweight and have heart disease and type 2 ... testosterone-deficient men for further testing and possible treatment is ... Health , a peer-reviewed publication from Mary Ann Liebert, ... Journal of Men,s Health website at ...
(Date:4/23/2014)... As evidence mounts showing the potential health benefits of ... people are taking supplements. And the chemical industry is ... supplements, health effects could deter growth, so the industry ... claims, according to the cover story in Chemical ... of the American Chemical Society. , Melody M. Bomgardner, ...
(Date:4/23/2014)... from the Cancer Science Institute of Singapore (CSI Singapore) ... cancer specific stem cell which causes gastric cancer. This ... for the treatment of this disease and other types ... Chan Shing Leng, Research Assistant Professor at CSI Singapore, ... of a cell surface protein, CD44v8-10, marks gastric cancer ...
(Date:4/23/2014)... Ritalin, may prevent the depletion of self-control, according to ... of the Association for Psychological Science. , Self-control can ... to focus attention on a boring textbook are hard ... for this difficulty: Exerting self-control for a long period ... on subsequent tasks. , "It is as if self-control ...
(Date:4/22/2014)... Government and industry leaders visited the New Jersey ... President Joel S. Bloom for the launch of ... corporation that provides a new model for business ... higher education assets and investment. U.S. Senator Cory ... CEO Joe Taylor, New Jersey Lieutenant Governor Kim ...
Breaking Medicine News(10 mins):Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:ADHD drug may help preserve our self-control resources 2Health News:Government and industry leaders herald launch of NJIT's New Jersey Innovation Institute 2
... a man in critical condition was hospitalized due to septicemic ... in the bloodstream//. Another women from Bernalillo County died last ... the first to die. ,Bite from an infected ... and pets can transmit plague. ,C. Mack Sewell, ...
... has described the criticism of its alleged negligence of ... and principal of NBMCH, Dr J B Saha, said ... ,Yesterday around 200 HIV-positive persons under the banner of ... at NBMCH and alleged that the HIV patients were ...
... A Government official reports, ‘Indonesia hasn’t shared the genetic information ... of disease control and environment, Nyoman Kandun//, at the Indonesian ... considered and discussed by the Government before any public release ... has been used for research purpose. ,A chain ...
... (Indonesia), Mark Snelling, explains about relief operations in earthquake tore ... 5,700 were died and more than a thousand were injured ... even 24 hours here is an eternity – said latest ... collapsed and 200,000 lost their homes. ,The most ...
... researchers at the Oxford have found that high doses of ... doubles the risk of a heart attack if taken in ... Journal study also explains that there was no danger for ... the benefits for patients who depend on it to lead ...
... by killing thousands of rainbow trout.Due to an outbreak, fishes ... case of viral haemorrhagic septicaemia (VHS) attack on wild fish ... the river Ouse in Britain. ,Scottish island of ... industry officials says there is no harm to human beings. ...
Cached Medicine News:Health News:High Doses Of Common Pain killers Can Double The Chances Of Heart attack 2
... DPX Duo is a SmartBeam platform providing ... measurements of the two most clinical sites ... and at a low radiation dose., ... on Windows, optimizes productivity and ensures consistant ...
... the highly respected single-source CT solution, from ... plaque. With its proprietary STRATON X-ray tube, ... of 0.33s, virtually freezing the hearts motion. ... delivers unprecedented diagnostic detail with up to ...
... Blood Pressure Monitoring System (ABPM) allows health ... blood pressure throughout the day. ABPM therapy ... hypertension and the data generated can be ... compact monitor has sophisticated tracking capabilities to ...
... on Philips' iSyntax technology, which uniquely solves ... image data sets using standard desktop PCs, ... new infrastructure is required. iSite Enterprise delivers ... displayed view, making Philips' image delivery method, ...
Medicine Products: